Udo S. Gaipl

Udo S. Gaipl

Translational Radiobiology, Friedrich-Alexander-Universität Erlangen-Nürnberg

Affiliated withFriedrich-Alexander-Universität Erlangen-NürnbergComprehensive Cancer Center Erlangen-EMN

Research Area

Biography

Udo S. Gaipl has not added Biography.
If you are Udo S. Gaipl and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Publication title

Cited by 1

2025

Other Publications

Article
Year
Low dose ionising radiation leads to a NF-κB dependent decreased secretion of active IL-1β by activated macrophages with a discontinuous dose-dependency.

International journal of radiation biology| PubMed ID: 22545750

2012
2012
2012
2013
2014
2014
2014
2015
Radio-immunotherapy: the focused beam expands.

The Lancet. Oncology| PubMed ID: 26095779

2015
2015
2015
2016
Primary glioblastoma multiforme tumors and recurrence : Comparative analysis of the danger signals HMGB1, HSP70, and calreticulin.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]| PubMed ID: 26646311

2016
Combination of ionising radiation with hyperthermia increases the immunogenic potential of B16-F10 melanoma cells in vitro and in vivo.

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group| PubMed ID: 26754406

2016
Erratum to: Primary glioblastoma multiforme tumors and recurrence: comparative analysis of the danger signals HMGB1, HSP70, and calreticulin.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]| PubMed ID: 26809739

2016
[EGFR inhibition in NSCLC tumor cell lines : Influence on cell cycle and tumor control].

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]| PubMed ID: 27169393

2016
2016
2016
2016
2016
2016
2016
Interconnection between DNA damage, senescence, inflammation, and cancer.

Frontiers in bioscience (Landmark edition)| PubMed ID: 27814618

2017
2016
2017
2017
2017
2017
2017
2017
2017
[Durvalumab improves prognosis of stage III non-small-cell lung cancer after definitive chemoradiotherapy].

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]| PubMed ID: 29374302

2018
2019
Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]| PubMed ID: 29500551

2018
2019
2016
2018
Low-Dose Radiotherapy Has No Harmful Effects on Key Cells of Healthy Non-Inflamed Joints.

International journal of molecular sciences| PubMed ID: 30332826

2018
2018
2019
2019
2019
2019
Immune biological rationales for the design of combined radio- and immunotherapies.

Cancer immunology, immunotherapy : CII| PubMed ID: 31953578

2020
2020
[Promising results of the combination of radiotherapy and pembrolizumab in metastatic NSCLC].

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]| PubMed ID: 32040692

2020
Early Mortality of Brain Cancer Patients and its Connection to Cytomegalovirus Reactivation During Radiochemotherapy.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 32060103

2020
2020
2020
2020
2020
2020
2020
2020
2020
2020
2020
Radon Exposure-Therapeutic Effect and Cancer Risk.

International journal of molecular sciences| PubMed ID: 33396815

2020
2020
2021
2021
2021
2021
2021
2021
2021
Head and neck tumor cells treated with hypofractionated irradiation die via apoptosis and are better taken up by M1-like macrophages.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]| PubMed ID: 34665291

2022
2021
2021
2021
[Definitive chemoradiotherapy of locally advanced head and neck cancer in combination with immune checkpoint inhibition-new concepts required].

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]| PubMed ID: 34873636

2022
2021
2022
2022
2022
2022
2022
Detailed analyses of the impact of multimodal cancer therapy with hyperthermia and radiotherapy on the immune phenotype of human glioblastoma cells.

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group| PubMed ID: 35676615

2022
Tumor-specific radiosensitizing effect of the ATM inhibitor AZD0156 in melanoma cells with low toxicity to healthy fibroblasts.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]| PubMed ID: 36229655

2023
2022
Normofractionated irradiation and not temozolomide modulates the immunogenic and oncogenic phenotype of human glioblastoma cell lines.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]| PubMed ID: 36480032

2023
Low-dose radiotherapy of osteoarthritis: from biological findings to clinical effects-challenges for future studies.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]| PubMed ID: 36602569

2023
2023
2023
2023
2023
[No abscopal effects of immunotherapy combined with stereotactic radiation therapy in Merkel cell carcinoma].

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]| PubMed ID: 37042974

2023
2023
2023
2022
2023
Broadband microwave spiral applicator (105-125 MHz) for examinations of hyperthermia-induced tumor cell death forms - first analyses with human breast cancer cells.

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group| PubMed ID: 37813393

2023
2023
Immune modulation during anti-cancer radio(immuno)therapy.

International review of cell and molecular biology| PubMed ID: 38225105

2024
2024
2023
2024
Effect of micro- and nanoplastic particles on human macrophages.

Journal of hazardous materials| PubMed ID: 38642497

2024
2024
2024
2024
2024
The Segment Anything foundation model achieves favorable brain tumor auto-segmentation accuracy in MRI to support radiotherapy treatment planning.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]| PubMed ID: 39503868

2025
2024
2024
2025